harvard medical school: "cgrp: a new era for migraine treatment." .
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
http://lm360.us/Stoesz-mother-of-Beddo-from-Muhasaari?Beagleson=114